Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Smoking

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    June 2019
  1. LEGG T, Peeters S, Chamberlain P, Gilmore AB, et al
    The Philip Morris-funded Foundation for a Smoke-Free World: tax return sheds light on funding activities.
    Lancet. 2019;393:2487-2488.
    PubMed     Text format    


    May 2019
  2. DRANSFIELD M, Stolz D, Kleinert S
    Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission.
    Lancet. 2019;393:1786-1788.
    PubMed     Text format    


    March 2019
  3. LAMB N
    E-cigarettes.
    Lancet. 2019;393:876.
    PubMed     Text format    


    September 2018

  4. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.
    Lancet. 2018;392:1072-1088.
    PubMed     Text format     Abstract available


    August 2018
  5. NEWTON JN, Dockrell M, Marczylo T
    Electronic cigarettes: adolescent health and wellbeing - Authors' reply.
    Lancet. 2018;392:474.
    PubMed     Text format    


  6. PETERS MJ
    Electronic cigarettes: adolescent health and wellbeing.
    Lancet. 2018;392:473-474.
    PubMed     Text format    


  7. BANDARA AN, Mehrnoush V
    Electronic cigarettes: adolescent health and wellbeing.
    Lancet. 2018;392:473.
    PubMed     Text format    


    July 2018
  8. BRITTON J
    Denicotinised cigarettes.
    Lancet. 2018;392:104-105.
    PubMed     Text format    


    April 2018
  9. WANG C, Xu J, Yang L, Xu Y, et al
    Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Lancet. 2018;391:1706-1717.
    PubMed     Text format     Abstract available


  10. THE LANCET
    UK COPD treatment: failing to progress.
    Lancet. 2018;391:1550.
    PubMed     Text format    


    March 2018
  11. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Text format     Abstract available


    February 2018
  12. NEWTON JN, Dockrell M, Marczylo T
    Making sense of the latest evidence on electronic cigarettes.
    Lancet. 2018;391:639-642.
    PubMed     Text format    


    November 2017
  13. GARTNER C, Miller A, Bonevski B
    Extending survival for people with hepatitis C using tobacco dependence treatment.
    Lancet. 2017;390:2033.
    PubMed     Text format    


    September 2017
  14. BARNETT R
    Lung cancer.
    Lancet. 2017;390:928.
    PubMed     Text format    


    August 2017
  15. RIDKER PM, MacFadyen JG, Thuren T, Everett BM, et al
    Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32247.
    PubMed     Text format     Abstract available


    July 2017
  16. THE LANCET
    Where next for UK tobacco control?
    Lancet. 2017;390:96.
    PubMed     Text format    


    January 2017
  17. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women.
    Lancet. 2017 Jan 31. pii: S0140-6736(16)32380.
    PubMed     Text format     Abstract available


  18. THE LANCET
    Tobacco elimination: an economic and public health imperative.
    Lancet. 2017;389:225.
    PubMed     Text format    


    October 2016
  19. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
    Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
    Lancet. 2016;388:1939-1951.
    PubMed     Text format     Abstract available



  20. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1659-1724.
    PubMed     Text format     Abstract available


    July 2016
  21. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Smoking is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: